Abstract
Impending changes in heart allocation policy in the US may impact listing strategies. Percutaneous LVADs will have increased priority in the new system. We sought to compare heart transplant outcomes by listing strategy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
